Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Wednesday. The company traded as high as $10.58 and last traded at $10.58, with a volume of 300 shares traded. The stock had previously closed at $10.1680.
Aspen Pharmacare Price Performance
The company has a debt-to-equity ratio of 0.12, a current ratio of 2.54 and a quick ratio of 1.68. The company’s 50-day moving average price is $9.73 and its two-hundred day moving average price is $8.76.
Aspen Pharmacare Company Profile
Aspen Pharmacare is a South African pharmaceutical company headquartered in Durban. Founded in 1997, it develops, manufactures and markets branded and generic medicines for patients and healthcare providers. The company’s product portfolio includes prescription and over-the-counter medicines across a range of therapeutic areas, as well as specialized products such as injectable medicines, anesthetics and treatments for thrombosis. Aspen also operates pharmaceutical manufacturing facilities and supplies medicines to other companies and healthcare markets.
Featured Articles
- Five stocks we like better than Aspen Pharmacare
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
